This inventor holds 5 USPTO granted patents and 2 published patent applications. Top assignee: Quanterix Corporation. Active years: 2017-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Winchester, MA (US) (2017)
- Billerica, MA (US) (2023)
Company Filing History:
Years Active: 2017-2025
Title: Lei Chang: Innovator in Neurobiological Diagnostics
Introduction
Lei Chang is a prominent inventor based in Winchester, MA (US), known for his significant contributions to the field of neurobiological diagnostics. With a total of five patents to his name, Chang has made remarkable strides in the quantification of biomarkers that are crucial for understanding various physiological conditions.
Latest Patents
Chang's latest patents include innovative immunoassays designed to detect neurofilament light chain (NF-L) in physiological samples. The first patent focuses on the quantification of NF-L in liquid samples derived from physiological fluids, such as venous blood. This technology aims to identify the presence or absence of specific physiological conditions by measuring NF-L concentrations. The second patent expands on this concept by quantifying multiple biomarkers, including NF-L, GFAP, UCH L1, and Tau, to provide a comprehensive assessment of physiological states.
Career Highlights
Chang is currently associated with Quanterix Corporation, a company that specializes in advanced diagnostic solutions. His work at Quanterix has positioned him as a leader in the development of cutting-edge technologies that enhance the understanding of neurological disorders.
Collaborations
Chang collaborates with notable colleagues, including Linan Song and David Wilson, who contribute to the innovative research environment at Quanterix Corporation.
Conclusion
In summary, Lei Chang is a distinguished inventor whose work in neurobiological diagnostics is paving the way for advancements in medical technology. His patents reflect a commitment to improving diagnostic accuracy and understanding of neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
